From Yahoo Finance: 2025-06-08 12:00:00

Palantir Technologies is riding high on the artificial intelligence wave, with shares up nearly 60% this year. In contrast, UnitedHealth Group has faced operational challenges, causing its stock to plummet by over 40%. Despite the differences, the valuation trends between these two stocks present a compelling case for investors to consider.

Palantir’s Artificial Intelligence Platform (AIP) has been a game-changer, leading to revenue acceleration and profitability. While the company historically relied on government contracts, AIP has diversified its revenue streams across various sectors like finance, supply chain, and aviation.

Palantir’s stock price has soared, with a price-to-sales ratio of 97, raising concerns about its valuation. In contrast, UnitedHealth’s stock trades at a forward price-to-earnings multiple of just 13, making it an attractive option for investors looking to buy the dip.

As Palantir’s stock reaches all-time highs, some investors are cautious about chasing the momentum. On the other hand, UnitedHealth’s recent challenges have made its stock look more appealing to those seeking value opportunities.

The Motley Fool Stock Advisor team has identified 10 top stocks for investors to consider, with Palantir Technologies not making the cut. With historical returns outperforming the market, it might be worth exploring other investment options beyond Palantir.

Read more: Palantir Stock vs. UnitedHealth Group Stock